GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Grand Brilliance Group Holdings Ltd (HKSE:08372) » Definitions » Cash, Cash Equivalents, Marketable Securities

Grand Brilliance Group Holdings (HKSE:08372) Cash, Cash Equivalents, Marketable Securities : HK$53.46 Mil (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Grand Brilliance Group Holdings Cash, Cash Equivalents, Marketable Securities?

Grand Brilliance Group Holdings's quarterly cash, cash equivalents, marketable securities declined from Mar. 2023 (HK$61.86 Mil) to Jun. 2023 (HK$0.00 Mil) but then increased from Jun. 2023 (HK$0.00 Mil) to Sep. 2023 (HK$53.46 Mil).

Grand Brilliance Group Holdings's annual cash, cash equivalents, marketable securities declined from Mar. 2021 (HK$70.26 Mil) to Mar. 2022 (HK$55.75 Mil) but then increased from Mar. 2022 (HK$55.75 Mil) to Mar. 2023 (HK$61.86 Mil).


Grand Brilliance Group Holdings Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Grand Brilliance Group Holdings's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Brilliance Group Holdings Cash, Cash Equivalents, Marketable Securities Chart

Grand Brilliance Group Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial 56.97 70.64 70.26 55.75 61.86

Grand Brilliance Group Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.39 - 61.86 - 53.46

Grand Brilliance Group Holdings Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Grand Brilliance Group Holdings  (HKSE:08372) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Grand Brilliance Group Holdings Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Grand Brilliance Group Holdings's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Grand Brilliance Group Holdings (HKSE:08372) Business Description

Traded in Other Exchanges
N/A
Address
6 Sha Tsui Road, The Octagon, Units 2901-2903 and 2905, 29th Floor, New Territories, Tsuen Wan, Hong Kong, HKG
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. The company serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.
Executives
Miu Yin Shun Andrew 2202 Interest of your spouse
Wong Bik Kwan Bikie 2101 Beneficial owner
B&a Success Limited 2101 Beneficial owner

Grand Brilliance Group Holdings (HKSE:08372) Headlines

No Headlines